Ampio Pharmaceuticals (AMPE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,632 | -16,337 | -17,075 | -15,894 | -13,630 |
| Depreciation Amortization | 127 | 1,048 | 1,094 | 1,177 | 1,272 |
| Other Working Capital | 15 | -2,974 | 2,580 | -1,441 | 1,359 |
| Other Operating Activity | -74 | -2,865 | -688 | 1,429 | -4,384 |
| Operating Cash Flow | $-8,564 | $-21,128 | $-14,089 | $-14,729 | $-15,383 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -97 | -63 | -22 |
| Investing Cash Flow | $N/A | $N/A | $-97 | $-63 | $-22 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 98 | N/A | 32,548 | 26,974 | 16,016 |
| Other Financing Activity | -98 | -111 | -1,816 | -1,368 | -1,664 |
| Financing Cash Flow | $N/A | $-111 | $30,732 | $25,606 | $14,352 |
| Beginning Cash Position | 12,653 | 33,892 | 17,346 | 6,532 | 7,585 |
| End Cash Position | 4,089 | 12,653 | 33,892 | 17,346 | 6,532 |
| Net Cash Flow | $-8,564 | $-21,239 | $16,546 | $10,814 | $-1,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,564 | -21,128 | -14,089 | -14,729 | -15,383 |
| Capital Expenditure | N/A | N/A | -97 | -63 | -22 |
| Free Cash Flow | -8,564 | -21,128 | -14,186 | -14,792 | -15,405 |